Literature DB >> 20484202

Developing an instrument to measure heart failure disease management program intensity and complexity.

Barbara Riegel1, Christopher S Lee, Julie Sochalski.   

Abstract

BACKGROUND: Comparing disease management programs and their effects is difficult because of wide variability in program intensity and complexity. The purpose of this effort was to develop an instrument that can be used to describe the intensity and complexity of heart failure (HF) disease management programs. METHODS AND
RESULTS: Specific composition criteria were taken from the American Heart Association (AHA) taxonomy of disease management and hierarchically scored to allow users to describe the intensity and complexity of the domains and subdomains of HF disease management programs. The HF Disease Management Scoring Instrument (HF-DMSI) incorporates 6 of the 8 domains from the taxonomy: recipient, intervention content, delivery personnel, method of communication, intensity/complexity, and environment. The 3 intervention content subdomains (education/counseling, medication management, and peer support) are described separately. In this first test of the HF-DMSI, overall intensity (measured as duration) and complexity were rated using an ordinal scoring system. Possible scores reflect a clinical rationale and differ by category, with zero given only if the element could potentially be missing (eg, surveillance by remote monitoring). Content validity was evident as the instrument matches the existing AHA taxonomy. After revision and refinement, 2 authors obtained an inter-rater reliability intraclass correlation coefficient score of 0.918 (confidence interval, 0.880 to 0.944, P<0.001) in their rating of 12 studies. The areas with most variability among programs were delivery personnel and method of communication.
CONCLUSIONS: The HF-DMSI is useful for describing the intensity and complexity of HF disease management programs.

Entities:  

Mesh:

Year:  2010        PMID: 20484202     DOI: 10.1161/CIRCOUTCOMES.109.877324

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  7 in total

1.  Toward phase 4 trials in heart failure: A social and corporate responsibility of the medical profession.

Authors:  Pupalan Iyngkaran; Glen S Beneby
Journal:  World J Methodol       Date:  2015-12-26

Review 2.  The Heart Failure with Preserved Ejection Fraction Conundrum-Redefining the Problem and Finding Common Ground?

Authors:  P Iyngkaran; M C Thomas; C Neil; M Jelinek; M Cooper; J D Horowitz; D L Hare; D M Kaye
Journal:  Curr Heart Fail Rep       Date:  2020-04

3.  Part 1: The Wider Considerations in Translating Heart Failure Guidelines.

Authors:  Pupalan Iyngkaran; Andrew Wilson; James Wong; David Prior; David Kaye; David L Hare; Peter Bergin; Michael Jelinem
Journal:  Curr Cardiol Rev       Date:  2021

4.  Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials.

Authors:  Minlu Li; Yuan Li; Qingtong Meng; Yinyin Li; Xiaomeng Tian; Ruixia Liu; Jinbo Fang
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

5.  Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scan.

Authors:  Harindra C Wijeysundera; Gina Trubiani; Lusine Abrahamyan; Nicholas Mitsakakis; William Witteman; Mike Paulden; Gabrielle van der Velde; Kori Kingsbury; Murray Krahn
Journal:  BMC Health Serv Res       Date:  2012-08-03       Impact factor: 2.655

6.  Northern Territory Heart Failure Initiative-Clinical Audit (NTHFI-CA)-a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale.

Authors:  Pupalan Iyngkaran; Jeff Tinsley; David Smith; Mark Haste; Kangaharan Nadarajan; Marcus Ilton; Malcolm Battersby; Simon Stewart; Alex Brown
Journal:  BMJ Open       Date:  2014-01-29       Impact factor: 2.692

7.  Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction.

Authors:  Fotini Kalogirou; Faye Forsyth; Martha Kyriakou; Rhys Mantle; Christi Deaton
Journal:  ESC Heart Fail       Date:  2020-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.